A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds
|
|||||
|
|
Pharmaceutical company Janssen Research and Development and University of Utah Health in Salt Lake City are studying genetic factors linked to higher suicide risks. . . . → Read More: University, Drug Maker Partner on Suicide Genetics A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments Outdoor tests of a genetically engineered diamondback moth, a difficult agricultural pest, altered to stop reproducing and collapse the species, are about to get underway. . . . → Read More: Field Tests of Genetically Modified Moths to Begin A simpler technique using nanoscale particles was shown in lab tests to deliver messenger RNA to reprogram cells for gene therapies, including changes in T-cells in the immune system now approved to treat a type of leukemia. . . . → Read More: Simple Cell Programming Designed for Gene Therapies  One comment - (Comments are closed)  New products  biomedical, biotechnology, cancer, genomics, life sciences, materials science, nanotechnology, patent, pharmaceuticals, physical sciences, stem cells, university A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems. . . . → Read More: Forensic Genomics Company Spun-Off From Illumina Comments are closed Joint ventures/collaborations biotechnology, entrepreneurs, genomics, life sciences, medical device, software, venture capital Global drug maker AstraZeneca is acquiring an option to license the rights to a technology based on genetic material transcribed from DNA, for new respiratory disease treatments. . . . → Read More: AstraZeneca, Biotech Partner on Messenger RNA Therapies Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals, U.K. A team of geneticists and computer scientists developed a technique of analyzing disease-causing mutations in a human genome without revealing other genetic data. . . . → Read More: Cryptography Technique Boosts Genomic Privacy One comment - (Comments are closed) New products biomedical, computer science, engineering, genomics, life sciences, mathematics, medical device, physical sciences, software, university A clinical trial is underway testing a genetically engineered virus to kill cancer cells, then stimulate the immune system to treat solid tumor cancers. . . . → Read More: Trial Testing Engineered Virus as Cancer Treatment One comment - (Comments are closed) New products biomedical, biotechnology, cancer, clinical trials, entrepreneurs, genomics, life sciences, pharmaceuticals A coalition of a patient advocacy organization, research institute, and cancer research company are implanting mice with human tumors to help study a rare form of cancer. . . . → Read More: Alliance to Develop Rare Cancer Preclinical Models One comment - (Comments are closed) Joint ventures/collaborations biomedical, cancer, genomics, life sciences, medical device, preclinical |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
